Armata Pharmaceuticals, Inc. (ARMP) Stock Grade

About Armata Pharmaceuticals, Inc.'s fundamentals

Armata Pharmaceuticals is a small-cap biotech company with a market capitalization of $227.6 million that reported a net loss in its latest annual statement, reflected in an extreme negative net margin of -3544.0%. The company experienced a revenue decline of 5.2% year-over-year, indicating contracting sales. With no dividend yield and unprofitable operations, the company is in a development or early commercialization phase typical of biotech firms investing heavily in research and product development rather than generating shareholder returns through distributions.